Treatment in early psychosis with N-acetyl-cysteine for 6 months improves low-level auditory processing: Pilot study.
Fiche du document
- doi: 10.1016/j.schres.2017.07.008
- issn: 0920-9964
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.schres.2017.07.008
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/28711476
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1573-2509
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_00A3B9194A8F2
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Commonwealth, The Administration Psychotic disorders Psychosis Political thought Government Political theory Civil government Commonwealth, The Science, Political Administration Politics Administration Administration Public administration--Law and legislation Law, Administrative Estates, Administration of AdministrationCiter ce document
C. Retsa et al., « Treatment in early psychosis with N-acetyl-cysteine for 6 months improves low-level auditory processing: Pilot study. », Serveur académique Lausannois, ID : 10.1016/j.schres.2017.07.008
Métriques
Partage / Export
Résumé
Sensory impairments constitute core dysfunctions in schizophrenia. In the auditory modality, impaired mismatch negativity (MMN) has been observed in chronic schizophrenia and may reflect N-methyl-d-aspartate (NMDA) hypo-function, consistent with models of schizophrenia based on oxidative stress. Moreover, a recent study demonstrated deficits in the N100 component of the auditory evoked potential (AEP) in early psychosis patients. Previous work has shown that add-on administration of the glutathione precursor N-acetyl-cysteine (NAC) improves the MMN and clinical symptoms in chronic schizophrenia. To date, it remains unknown whether NAC also improves general low-level auditory processing and if its efficacy would extend to early-phase psychosis. We addressed these issues with a randomized, double-blind study of a small sample (N=15) of early psychosis (EP) patients and 18 healthy controls from whom AEPs were recorded during an active, auditory oddball task. Patients were recorded twice: once prior to NAC/placebo administration and once after six months of treatment. The N100 component was significantly smaller in patients before NAC administration versus controls. Critically, NAC administration improved this AEP deficit. Source estimations revealed increased activity in the left temporo-parietal lobe in patients after NAC administration. Overall, the data from this pilot study, which call for replication in a larger sample, indicate that NAC improves low-level auditory processing in early psychosis.